Spyre Therapeutics, Inc. SYRE · Transcripts

125

Spyre Therapeutics, Inc. is a biotechnology firm operating at the preclinical stage, dedicated to cr...

Price109

Market Cap10.23 B

Float86.48 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login